Entrada Therapeutics (TRDA) Other Non-Current Assets: 2022-2025
Historic Other Non-Current Assets for Entrada Therapeutics (TRDA) over the last 4 years, with Sep 2025 value amounting to $4.0 million.
- Entrada Therapeutics' Other Non-Current Assets changed negligibly% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $4.0 million for FY2024, which is negligibly% changed negligibly from last year.
- According to the latest figures from Q3 2025, Entrada Therapeutics' Other Non-Current Assets is $4.0 million, which was down 0.00% from $4.0 million recorded in Q2 2025.
- Entrada Therapeutics' 5-year Other Non-Current Assets high stood at $13.8 million for Q1 2023, and its period low was $4.0 million during Q1 2022.
- In the last 3 years, Entrada Therapeutics' Other Non-Current Assets had a median value of $4.0 million in 2025 and averaged $4.8 million.
- In the last 5 years, Entrada Therapeutics' Other Non-Current Assets spiked by 250.46% in 2023 and then crashed by 71.47% in 2024.
- Quarterly analysis of 4 years shows Entrada Therapeutics' Other Non-Current Assets stood at $5.2 million in 2022, then dropped by 24.18% to $4.0 million in 2023, then remained steady at $4.0 million in 2024, then remained steady at $4.0 million in 2025.
- Its Other Non-Current Assets stands at $4.0 million for Q3 2025, versus $4.0 million for Q2 2025 and $4.0 million for Q1 2025.